Congenital external ophthalmoplegia (CFEOM) is an uncommon autosomal dominant condition that has previously been mapped to the pericentromeric region of chromosome 12 in seven families with no evidence of locus heterogeneity.
Congenital
external ophthalmoplegia (CFEOM, MIM 135700) is an uncommon, highly penetrant autosomal dominant disorder characterised by bilateral, non-progressive ptosis and generalised external ophthalmoplegia. Laughlin' characterised the syndrome as a congenital condition encompassing (1) extraocular muscle fibrosis, (2) adhesions between the muscles, Tenon's capsule (one of the anterior tissues of the eye), and the globe, (3) absence of elevation or depression of the eyes, (4) little or no horizontal movement, (5) fixation of the eyes 20-30°below the horizontal, and (6) blepharoptosis with chin elevation. 2 Residual ocular movements are often abnormal3 and there may be associated amblyopia. There is occasionally evidence of additional neurological features, including mild facial weakness. 4 Genetic analysis among families with an apparently fully penetrant form of the disorder showed linkage to markers within a region of approximately 3 cM around the centromere of chromosome 12, with no evidence of locus heterogeneity.4 5The closest flanking markers were D12S1584 on 12p and D12S1668 on 12q. As yet, no obvious candidate genes have been identified within this region. A second form of CFEOM, associated with globes frozen in extreme abduction, which is inherited in an autosomal recessive fashion, has recently been linked to chromosome 1 1q3.6 A potentially related locus, responsible for autosomal dominant ptosis with normal extraocular movements, has been identifed on chromosome lp32-p34. 1.7 We have identified three families in which affected members have the classical phenotype of autosomal dominant CFEOM and tested them for linkage to the pericentromeric region restricted ocular movement, infraducted globes, and strabismic position. All subjects included in the molecular analyses were examined by one of the authors. Blood samples were obtained from family members and DNA extracted using conventional methods.
PCR GENOTYPING
The chromosome 12 microsatellite markers D12S1631 (Afma288wd5), D12S345 (AFM296yg5), D12S331 (AFMO92wd 11), D12S1048 (C-ATA29HO1), D12S1584 (AFM136xf6), and D12S1668 (AFMb320 wd9) were used for haplotype analysis of the region. Analysis of Ip The pedigrees of families CFEOM1-3 are shown in fig 2. As others have described,4 there is variability, both within and between families, in the degree and symmetry of ptosis and strabismus and the degree to which movement of individual muscles was affected. However, affected subjects in all three families fitted the clinical description of classical CFEOM: congenital, non-progressive problems associated with bilateral ptosis, chin elevation, infraducted globes with reduced/absent elevation, reduced horizontal movements, and a strabismic position (table 1) . No unaffected subject had any signs of the disorder. No affected subject had any additional neurological features, although affected subject 11.5 in family CFEOM1 had mild corectopia (distorted pupils) and a sectoral cortical cataract, which had no effect on vision at the age of 36. No other member of the family had similar clinical signs. 
